Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center

Authors

Mohamed Hendawi, Advocate Aurora HealthFollow
Luke Peterson
Eyob Tadesse, Advocate Aurora HealthFollow
Frank Wolf
Thomas BrownFollow
Michael A. Thompson, Advocate Aurora HealthFollow

Recommended Citation

Hendawi M, Peterson L, Tadesse Ea, et al. Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center. Journal of clinical oncology. 2021;39:e21047-e21047.

Affiliations

Aurora Cancer Care, Advocate Aurora Health

Presentation Notes

ASCO Annual Meeting 2021; June 2021; Chicago, IL

Document Type

Abstract